Combining orbital intensity modulated radiation therapy with periorbital triamcinolone acetonide injection for Graves' orbitopathy. [PDF]
Int J OphthalmolJian H, Ma RX, He WM.
europepmc +1 more source
Clinical predictors of tocilizumab response in moderate-to-severe thyroid eye disease: a large single-center retrospective cohort study. [PDF]
Front Endocrinol (Lausanne)Lu M, Wang L, Wang Z, Song Z.
europepmc +1 more source
Effective treatment of pretibial myxoedema with tofacitinib: a case report and analysis of immunopathogenesis. [PDF]
Thyroid ResZhao CX, Zhao MD, Li X.
europepmc +1 more source
The impact of graves' orbitopathy on anterior segment structures and choroidal parameters. [PDF]
BMC OphthalmolSevimli N +3 more
europepmc +1 more source
Triglyceride-driven pathogenesis in thyroid-associated ophthalmopathy: a dual approach of clinical correlation and genetic causality. [PDF]
Int J OphthalmolCao JM, Chen HY, Zhang F, Xiong W.
europepmc +1 more source
Redefining Treatment Paradigms in Thyroid Eye Disease: Current and Future Therapeutic Strategies. [PDF]
J Clin MedCiarmatori N +2 more
europepmc +1 more source
Low risk of thyroid eye disease (TED) following radioiodine (RAI) therapy in a multidisciplinary setting: a retrospective cohort study. [PDF]
Thyroid ResVekinis JS +6 more
europepmc +1 more source
Evaluation of retinal nerve fiber and ganglion cell layer abnormalities using optical coherence tomography in thyroid-associated orbitopathy. [PDF]
Arq Bras OftalmolAndrade AL +6 more
europepmc +1 more source
A preliminary study developing a scoring model incorporating fibrinogen-like protein 2 for predicting glucocorticoid resistance in thyroid eye disease. [PDF]
Thyroid ResMatsuzawa K +11 more
europepmc +1 more source